Israel secures more Remdesivir to treat COVID-19 patients

The Health Ministry has secured more of the potentially life-saving drug Remdesivir, which is used to treat coronavirus patients, a source in the know revealed to The Jerusalem Post. Earlier in the week, health officials said that the country was running low and some hospitals, including Sheba Medical Center at Tel Hashomer and Rambam Medical Center in Haifa, reported that they had none left. “We are trying to get a hold of it,” Sheba's Galia Rahav told the Post on Sunday, accusing US President Donald Trump of buying all the drug for America and leaving none for the rest of the world, including America's allies. Remdesivir has proved effective in the treatment of some patients with severe COVID-19, the disease caused by the novel coronavirus. Researchers at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill, as well as Gilead Sciences, the creators of the drug, reported that Remdesivir potently inhibited the virus in human lung cell cultures and that it improved lung function in mice infected with the virus, a report by Vanderbilt said earlier this week. Other studies suggested that patients who received the drug recovered more quickly. It is unclear how Israel obtained the drug, but sources told the Post earlier this week that the country would not refrain from using “intelligence” or “diplomatic” means to secure it.

Israel secures more Remdesivir to treat COVID-19 patients

Several hospitals, including Sheba Medical Center at Tel Hashomer and Rambam Medical Center in Haifa, had reported they were out.

Chocolate spread – the truth behind the calorie bomb

The foods that could cause dementia

Israel secures more Remdesivir to treat COVID-19 patients

Several hospitals, including Sheba Medical Center at Tel Hashomer and Rambam Medical Center in Haifa, had reported they were out.

See more on